Company: CGCT
Filing Date: 2025-03-05
Form Type: S-1/A
Source: 0001104659-25-020969
Chunk: 92

Company: Cartesian Growth Corp III
Filing Date: 2025-03-05
Form: S-1/A
Chunk 92
---
 would be absent
any conflicts of interest.

Because our initial shareholders, officers and directors may lose their entire investment in us if our initial business combination is not completed (other than with respect to public shares they may acquire during or after this offering), a conflict of interest may arise in determining whether a particular business combination target is appropriate for our initial business combination.

Pursuant to certain subscription agreements dated
October 29, 2024, on November 12, 2024, our initial shareholders paid an aggregate of $25,000, or approximately $0.004 per
share, to cover certain of our offering costs in exchange for an aggregate of 5,750,000 founder shares.

<div align='center'>54</div>

Prior to the initial investment in the company
of $25,000 by our initial shareholders, the company had no assets, tangible or intangible. The purchase price of the founder shares was
determined by dividing the amount of cash contributed to the company by the number of founder shares issued. The number of founder shares
outstanding was determined based on the expectation that the total size of this offering would be a maximum of 23,000,000 units
if the underwriters’ over-allotment option is exercised in full, and therefore that such founder shares would represent 20% of
the outstanding ordinary shares after this offering. Our public shareholders may incur material dilution due to such anti-dilution adjustments
that result in the issuance of Class A ordinary shares on a greater than one-to-one basis upon conversion. Up to 750,000 of the
founder shares will be surrendered by our sponsor to us for no consideration depending on the extent to which the underwriters’
over-allotment option is exercised. The founder shares will be worthless if we do not complete an initial business combination, except
to the extent they receive liquidating distributions from assets outside of the trust account. In addition, our sponsor and Cantor, the
representative of the underwriters, have committed to purchase an aggregate of 6,000,000 private placement warrants, each exercisable
to purchase one Class A ordinary share at $11.50 per share, at a price of $1.00 per private placement warrant, or $6,000,000 in
the aggregate, in a private placement that will close simultaneously with the closing of this offering. Of those 6,000,000 private placement
warrants, our sponsor has agreed to purchase 4,000,